HALE DAVID F
CIK: 0001024004
Director
Primary company: SANTARUS INC (SNTS)
HALE DAVID F is a corporate insider at SANTARUS INC (SNTS) filing SEC Form 4 transactions. 283 transactions across 8 companies, totaling $307,275 in purchases and $526,664 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 78,741 | - | - | 80,957 | 1/23/2025 Filed: 1/23/2025 | Filing → | |
| Award | 78,741 | $1.27 | $100K | 78,741 | 1/21/2025 Filed: 1/23/2025 | Filing → | |
| Award | 5,000 | $1.38 | $7K | 5,000 | 1/13/2025 Filed: 1/14/2025 | Filing → | |
Oncternal Therapeutics, Inc. ONCT | Award | 3,300 | - | - | 3,300 | 6/20/2024 Filed: 6/24/2024 | Filing → |
Oncternal Therapeutics, Inc. ONCT | Purchase | 266 | $9.04 | $2K | 29,673 | 2/23/2024 Filed: 2/27/2024 | Filing → |
Oncternal Therapeutics, Inc. ONCT | Purchase | 714 | $9.04 | $6K | 714 | 2/23/2024 Filed: 2/27/2024 | Filing → |
| Award | 10,000 | - | - | 10,000 | 1/4/2024 Filed: 1/5/2024 | Filing → | |
Oncternal Therapeutics, Inc. ONCT | Award | 37,500 | $0.00 | $0 | 37,500 | 6/28/2023 Filed: 6/30/2023 | Filing → |
| Award | 30,155 | $0.00 | $0 | 75,720 | 10/6/2022 Filed: 10/7/2022 | Filing → | |
| Award | 26,441 | $0.00 | $0 | 45,565 | 7/7/2022 Filed: 7/8/2022 | Filing → | |
Oncternal Therapeutics, Inc. ONCT | Award | 37,500 | $0.00 | $0 | 37,500 | 6/16/2022 Filed: 6/17/2022 | Filing → |
| Award | 15,466 | $0.00 | $0 | 19,124 | 4/7/2022 Filed: 4/8/2022 | Filing → | |
| Award | 5,000 | $0.00 | $0 | 5,000 | 1/3/2022 Filed: 1/5/2022 | Filing → | |
BIOCEPT INC BIOC | Sale | 71 | $4.07 | $289 | 796 | 12/9/2021 Filed: 12/10/2021 | Filing → |
BIOCEPT INC BIOC | Sale | 11 | $4.07 | $45 | 101 | 12/9/2021 Filed: 12/10/2021 | Filing → |
BIOCEPT INC BIOC | Sale | 363 | $4.06 | $1K | 3,114 | 12/9/2021 Filed: 12/10/2021 | Filing → |
| Purchase | 35,714 | - | - | 35,714 | 8/17/2021 Filed: 8/17/2021 | Filing → | |
| Conversion | 3,048 | $0.00 | $0 | 3,048 | 8/17/2021 Filed: 8/17/2021 | Filing → | |
| Conversion | 62,500 | $0.00 | $0 | 0 | 8/17/2021 Filed: 8/17/2021 | Filing → | |
| Conversion | 555,622 | $0.00 | $0 | 0 | 8/17/2021 Filed: 8/17/2021 | Filing → |
Type
Award
Shares
78,741
Price
-
Value
-
Type
Award
Shares
78,741
Price
$1.27
Value
$100K
Type
Award
Shares
5,000
Price
$1.38
Value
$7K
Oncternal Therapeutics, Inc.
ONCT
Type
Award
Shares
3,300
Price
-
Value
-
Oncternal Therapeutics, Inc.
ONCT
Type
Purchase
Shares
266
Price
$9.04
Value
$2K
Oncternal Therapeutics, Inc.
ONCT
Type
Purchase
Shares
714
Price
$9.04
Value
$6K
Type
Award
Shares
10,000
Price
-
Value
-
Oncternal Therapeutics, Inc.
ONCT
Type
Award
Shares
37,500
Price
$0.00
Value
$0
Type
Award
Shares
30,155
Price
$0.00
Value
$0
Type
Award
Shares
26,441
Price
$0.00
Value
$0
Oncternal Therapeutics, Inc.
ONCT
Type
Award
Shares
37,500
Price
$0.00
Value
$0
Type
Award
Shares
15,466
Price
$0.00
Value
$0
Type
Award
Shares
5,000
Price
$0.00
Value
$0
BIOCEPT INC
BIOC
Type
Sale
Shares
71
Price
$4.07
Value
$289
BIOCEPT INC
BIOC
Type
Sale
Shares
11
Price
$4.07
Value
$45
BIOCEPT INC
BIOC
Type
Sale
Shares
363
Price
$4.06
Value
$1K
Type
Purchase
Shares
35,714
Price
-
Value
-
Type
Conversion
Shares
3,048
Price
$0.00
Value
$0
Type
Conversion
Shares
62,500
Price
$0.00
Value
$0
Type
Conversion
Shares
555,622
Price
$0.00
Value
$0
AI Agent
Try asking...